Feasibility and Effects of Inspiratory Muscle Training Combined With Blood Flow Restriction for Frail Older Adults
1 de maio de 2026 atualizado por: Pei-Shan, Tsai, Taipei Medical University
Feasibility and Effects of Inspiratory Muscle Training Combined With Blood Flow Restriction for Frail Older Adults: A Pilot Randomized Controlled Trial
This randomized controlled trial study aims to evaluate the feasibility and preliminary efficacy of a combined inspiratory muscle training (IMT) and blood flow restriction (BFR) intervention in frail older adults.
Outcomes of interest include feasibility, physical function, respiratory muscle strength, handgrip strength, five-times sit-to-stand performance, body composition, frailty level, fall efficacy, blood pressure, and adverse events.
Visão geral do estudo
Status
Ainda não está recrutando
Condições
Intervenção / Tratamento
Descrição detalhada
This is a parallel randomized controlled trial. 30 participants who are older adults with frailty will be enrolled.
Eligible participants who complete the baseline measurements will be randomly allocated to a combined BFR and IMT intervention group (N=15) or in the control group with BFR and sham IMT (N=15).
Primary outcomes include feasibility and physical function (i.e., the Short Physical Performance Battery (SPPB), 6-minute walk test (6MWT), and Time Up and Go (TUG) test). Secondary outcomes include respiratory muscle strength, handgrip strength, five-times sit-to-stand performance, body composition, frailty level, fall efficacy, blood pressure, and adverse events. All outcomes will be assessed at baseline (T0) and immediately after the 6-week intervention period (T1) in both groups.
Tipo de estudo
Intervencional
Inscrição (Estimado)
30
Estágio
- Não aplicável
Contactos e Locais
Esta seção fornece os detalhes de contato para aqueles que conduzem o estudo e informações sobre onde este estudo está sendo realizado.
Contato de estudo
- Nome: Pei-Shan Tsai Professor, PhD
- Número de telefone: 6321 +886227361661
- E-mail: ptsai@tmu.edu.tw
Locais de estudo
-
-
-
Taipei, Taiwan, 11031
- Taipei Medical University
-
Contato:
- Pei-Shan Tsai Professor, PhD
- Número de telefone: 6321 +886227361661
- E-mail: ptsai@tmu.edu.tw
-
-
Critérios de participação
Os pesquisadores procuram pessoas que se encaixem em uma determinada descrição, chamada de critérios de elegibilidade. Alguns exemplos desses critérios são a condição geral de saúde de uma pessoa ou tratamentos anteriores.
Critérios de elegibilidade
Idades elegíveis para estudo
- Adulto mais velho
Aceita Voluntários Saudáveis
Não
Descrição
Inclusion Criteria:
- Community-dwelling adults aged 65 years and older who are classified as at least "vulnerable" using the Clinical Frailty Scale (score ≥4).
- Participants must have no cognitive impairment and be able to follow commands, as assessed by the Mini-Mental State Examination (MMSE).
Exclusion Criteria:
- (1) are unable to participate in exercise (e.g., due to severe musculoskeletal disorders)
- (2) have high-risk factors for exercise, such as uncontrolled hypertension (>150 mmHg systolic blood pressure (SBP) / >90 mmHg diastolic blood pressure (DBP), coagulation disorders, and deep venous thrombosis
- (3) have hematological disorders or are using hematology related-medications
- (4) have significant comorbidities, including a history of stroke, diabetes with severe complications, or cardiovascular diseases
- (5) chronic lung conditions (e.g., obstructive pulmonary disease, asthma), and
- (6) have participated in a structured exercise training program within the past 3 months at a frequency exceeding three sessions per week.
Plano de estudo
Esta seção fornece detalhes do plano de estudo, incluindo como o estudo é projetado e o que o estudo está medindo.
Como o estudo é projetado?
Detalhes do projeto
- Finalidade Principal: Tratamento
- Alocação: Randomizado
- Modelo Intervencional: Atribuição Paralela
- Mascaramento: Dobro
Armas e Intervenções
Grupo de Participantes / Braço |
Intervenção / Tratamento |
|---|---|
|
Experimental: Intervention group
Participants in the experimental group will receive a 6 week combined BFR and IMT intervention
|
Each session will last approximately 60 minutes and will include three components: (1) an initial 3-minute IMT exercise performed at an intensity corresponding to rating of perceived exertion (RPE) 11-13 on the Borg 6-20 scale, (2) a 50-minute low-intensity exercise program combined with BFR, and (3) a second 3-minute IMT session at the same target intensity. For the IMT, the protocol follows a progressive intensity model, starting with 30% of the maximum inspiratory pressure (MIP) in Week 1 to allow participants to become familiar with the technique. The intensity will gradually increase to a target of 60% MIP by Week 6, based on the participants' tolerance. For the BFR, during weeks 1-2, participants will train at constant loads. From weeks 2-6, training loads will be increased. Cuff pressure will be prescribed relative to the calculated arterial occlusion pressure (AOP): 50% in weeks 1-2, 60% in weeks 3-4, and 70% in weeks 5-6 for both lower- and upper-body exercises. |
|
Comparador Falso: Control group
Participants in the control group will receive a 6-week combined combined BFR and sham IMT intervention.
|
Participants in the control group will perform the identical BFR exercise protocol as the intervention group.
However, IMT will be delivered at 2% of MIP, which is considered a sham condition and has not been shown to improve respiratory muscle function
|
O que o estudo está medindo?
Medidas de resultados primários
Medida de resultado |
Descrição da medida |
Prazo |
|---|---|---|
|
Recruitment rate
Prazo: T0 = baseline; T1 = immediately after intervention
|
The recruitment rate will be calculated by dividing the number of recruited participants by the number of eligible participants
|
T0 = baseline; T1 = immediately after intervention
|
|
Attrition rate
Prazo: T0 = baseline; T1 = immediately after intervention
|
Attrition rate is the proportion of randomized participants who withdraw from the study or are lost to follow-up before completing the final assessment.
|
T0 = baseline; T1 = immediately after intervention
|
|
Exercise Enjoyment
Prazo: T0 = baseline; T1 = immediately after intervention
|
Enjoyment will be assessed using a single-item Exercise Enjoyment Scale, which asks participants, "How much did you enjoy the exercise session?).
Responses are rated on a 7 Likert scale ranging from 1 (not at all) to 7 (extremely)
|
T0 = baseline; T1 = immediately after intervention
|
|
Short Physical Performance Battery (SPPB)
Prazo: T0 = baseline; T1 = immediately after intervention
|
The SPPB consists of three components-standing balance, gait speed, and repeated chair stands-each scored from 0 to 4 and summed to a total score ranging from 0 (worst performance) to 12 (best performance).
Lower SPPB scores indicate poorer physical function and a higher risk of adverse outcomes, with scores below 10 predictive of all-cause mortality in older adults.
|
T0 = baseline; T1 = immediately after intervention
|
|
6-Minute Walk Test (6MWT)
Prazo: T0 = baseline; T1 = immediately after intervention
|
The 6MWT will be used to assess functional exercise capacity.
Participants will be instructed to walk as far as possible along a flat, straight course for 6 minutes, and the total distance is recorded.
|
T0 = baseline; T1 = immediately after intervention
|
|
Time Up to Go (TUG)
Prazo: T0 = baseline; T1 = immediately after intervention
|
The TUG test is used to assess functional mobility, balance, and fall risk in older adults, incorporating a series of dynamic activities.
Participants will be instructed to rise from a chair, walk three meters at a comfortable pace, turn around, walk back to the chair, and sit down.
The total time taken to complete the task is recorded, with longer times indicating poorer functional mobility and higher fall risk
|
T0 = baseline; T1 = immediately after intervention
|
Medidas de resultados secundários
Medida de resultado |
Descrição da medida |
Prazo |
|---|---|---|
|
Respiratory Muscle Strength
Prazo: T0 = baseline; T1 = immediately after intervention
|
We will use the S-Index Test to evaluate the respiratory muscle function based on maximum dynamic inspiratory pressure, which is a recommended tool developed by POWERbreathe.
Participants will be advised to avoid strenuous exercise for 24h and to rest in a sitting position for 15 minutes before the assessment.
Then, they performed eight inspiratory maneuvers in a standing position, divided into three to four series of two to three repetitions.
|
T0 = baseline; T1 = immediately after intervention
|
|
Handgrip Strength
Prazo: T0 = baseline; T1 = immediately after intervention
|
Handgrip strength will be evaluated to estimate the maximum upper-limb muscle function in older adults.
Participants will be seated with the shoulder adducted, the elbow flexed to 90°, and the forearm and wrist in a neutral position.
They will then be instructed to squeeze the dynamometer as forcefully as possible.
|
T0 = baseline; T1 = immediately after intervention
|
|
Five-times sit-to-stand
Prazo: T0 = baseline; T1 = immediately after intervention
|
The five-times sit-to-stand test is simple to administer and has been widely applied in both clinical and research settings.
Participants will sit with their backs against the chair and be instructed to stand and sit five times as quickly as possible.
|
T0 = baseline; T1 = immediately after intervention
|
|
Frailty level
Prazo: T0 = baseline; T1 = immediately after intervention
|
The Clinical Frailty Scale (CFS) is a 9-point global clinical measure ranging from 1 (very fit) to 9 (terminally ill), used to classify frailty severity in older adults.
A traditional Chinese version of the CFS has been validated in Taiwanese older adults, demonstrating acceptable inter-rater reliability and good criterion validity against established frailty measures
|
T0 = baseline; T1 = immediately after intervention
|
|
Fall Efficacy
Prazo: T0 = baseline; T1 = immediately after intervention
|
The short form of the Falls Efficacy Scale-International (FES-I) includes 7 items rated on a 4-point Likert scale from 1 (not at all concerned) to 4 (very concerned).
The total score ranges from 7 to 28, with higher values indicating greater concern about falling
|
T0 = baseline; T1 = immediately after intervention
|
|
Adverse events
Prazo: T0 = baseline; T1 = immediately after intervention
|
The study team will record adverse events during the intervention caused by the exercise, including falls, fractures, exercise-related pain, dizziness, muscle strain, sprains, respiratory and cardiac adverse events, and hospitalization.
|
T0 = baseline; T1 = immediately after intervention
|
|
Fat mass
Prazo: T0 = baseline; T1 = immediately after intervention
|
Fat mass will be assessed using a body composition analyzer and recorded in kilograms
|
T0 = baseline; T1 = immediately after intervention
|
|
Fat-free mass
Prazo: T0 = baseline; T1 = immediately after intervention
|
Fat-free mass will be assessed using a body composition analyzer and recorded in kilograms.
|
T0 = baseline; T1 = immediately after intervention
|
Outras medidas de resultado
Medida de resultado |
Descrição da medida |
Prazo |
|---|---|---|
|
The Borg Rating of Perceived Exertion (RPE) Scale
Prazo: T0 = baseline; T1 = immediately after intervention
|
The Borg RPE scale reflects an individual's subjective perception of exercise intensity, integrating sensations of physical effort, breathlessness, and fatigue.
The scale ranges from 6 to 20, where 6 indicates "no exertion at all" and 20 indicates "maximal exertion."
This RPE score will be assessed every training session
|
T0 = baseline; T1 = immediately after intervention
|
|
Automated Office Blood Pressure
Prazo: T0 = baseline; T1 = immediately after intervention
|
Automated Office Blood Pressure will be monitored before and after intervention to minimize cardiovascular risks and ensure that timely medical assistance is available for participants who experience any discomfort.
Upon arrival at the lab, participants will be asked to sit for at least 5 minutes before the first blood pressure reading; the average of two readings will be used for that visit
|
T0 = baseline; T1 = immediately after intervention
|
Colaboradores e Investigadores
É aqui que você encontrará pessoas e organizações envolvidas com este estudo.
Patrocinador
Datas de registro do estudo
Essas datas acompanham o progresso do registro do estudo e os envios de resumo dos resultados para ClinicalTrials.gov. Os registros do estudo e os resultados relatados são revisados pela National Library of Medicine (NLM) para garantir que atendam aos padrões específicos de controle de qualidade antes de serem publicados no site público.
Datas Principais do Estudo
Início do estudo (Estimado)
1 de maio de 2026
Conclusão Primária (Estimado)
1 de outubro de 2026
Conclusão do estudo (Estimado)
1 de outubro de 2026
Datas de inscrição no estudo
Enviado pela primeira vez
23 de abril de 2026
Enviado pela primeira vez que atendeu aos critérios de CQ
1 de maio de 2026
Primeira postagem (Real)
7 de maio de 2026
Atualizações de registro de estudo
Última Atualização Postada (Real)
7 de maio de 2026
Última atualização enviada que atendeu aos critérios de controle de qualidade
1 de maio de 2026
Última verificação
1 de maio de 2026
Mais Informações
Termos relacionados a este estudo
Palavras-chave
Termos MeSH relevantes adicionais
Outros números de identificação do estudo
- 2025-UAAT-UTS02
Plano para dados de participantes individuais (IPD)
Planeja compartilhar dados de participantes individuais (IPD)?
NÃO
Informações sobre medicamentos e dispositivos, documentos de estudo
Estuda um medicamento regulamentado pela FDA dos EUA
Não
Estuda um produto de dispositivo regulamentado pela FDA dos EUA
Não
Essas informações foram obtidas diretamente do site clinicaltrials.gov sem nenhuma alteração. Se você tiver alguma solicitação para alterar, remover ou atualizar os detalhes do seu estudo, entre em contato com register@clinicaltrials.gov. Assim que uma alteração for implementada em clinicaltrials.gov, ela também será atualizada automaticamente em nosso site .